Latest News and Press Releases

TORONTO, ONTARIO, July 15, 2022 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) ("Aeterna" or the "Company"), a specialty biopharmaceutical company developing and...

- Vote to approve share consolidation adjourned to July 6, 2022 TORONTO, ONTARIO, June 21, 2022 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) ("Aeterna" or the "Company"), a...

New York, United States, May 27, 2022 (GLOBE NEWSWIRE) -- Neurodegenerative diseases are a large and diverse group of disorders characterized by progressive deterioration of the function and...

TORONTO, ONTARIO, May 18, 2022 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (“Aeterna” or the “Company”), a specialty biopharmaceutical company developing and commercializing...

Glen Rock, N.J., March 23, 2022 (GLOBE NEWSWIRE) -- RespireRx Pharmaceuticals Inc. (OTCQ:RSPI) (“RespireRx” or the “Company”), a leader in the discovery and development of innovative and...

OT-101 is Oncotelic’s RNA Therapeutic Against TGF-βOT-101 has completed over six clinical trials against solid tumors with good efficacyOT-101 is currently undergoing a phase 1b trial in combination...

LOS ANGELES, Sept. 16, 2021 (GLOBE NEWSWIRE) -- In a conversation with Capital Market Laboratories (CMLviz), Chief Financial Officer of PagerDuty Howard Wilson had clear messages: The company is...

- Company continues to drive enrollment in pivotal intranasal abuse study evaluating ADAIR toward completion before year-end 2021 - ADAIR targeting the large and growing Adderall® segment of the...

LOS ANGELES, June 22, 2021 (GLOBE NEWSWIRE) -- In a conversation with Capital Market Laboratories (CMLviz), Chief Financial Officer of PagerDuty Howard Wilson had clear messages: The tailwinds that...

CHANDLER, Ariz., April 14, 2021 (GLOBE NEWSWIRE) -- USB Type-C with Power Delivery (PD) and open-source software are two technologies leading the next wave of wired connectivity. With Microchip...